Drug
Amg 701
Amg 701: highest development phase Phase 1, developed by Amgen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Amgen
Trials
| Drug | Phase | Indication |
|---|---|---|
| AMG 701 NCT04998747 | Phase 1 | Relapsed/Refractory Multiple Myeloma |
Latest
No recent events.
Follow Amg 701 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.